Impact of neo-adjuvant radiochemotherapy on bronchial tissue viability

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 2, 2010, Pages 461-466

  Hampel, Martina ^a   Dally, Iris ^a   Walles, Thorsten ^b,c   Steger, Volker ^c   Veit, Stefanie ^c   Kyriss, Thomas ^c   Friedel, Godehard ^c  

^a UNIVERSITY OF STUTTGART   (Germany)

^b FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^c Schillerhoehe Hospital   (Germany)

Author keywords

Bronchopleural fistula; Complications; Induction therapy; Locally advanced NSCLC; Viability

Indexed keywords

CISPLATIN; NAVELBINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; BRONCHOPLEURAL FISTULA; BRONCHUS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; DRUG DOSE REDUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL APPROACH; SURGICAL TECHNIQUE; THORACOTOMY; TISSUE SPECIFICITY;

AGED; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LENGTH OF STAY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TISSUE CULTURE TECHNIQUES;

EID: 74149095000     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.08.021     Document Type: Article

References (24)

1. Gudbjartsson T., Gyllstedt E., Pikwer A., and Jönsson P. Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy. Ann Thorac Surg 86 (2008) 376-382
2. Stamatis G., Djuric D., Eberhardt W., Pottkenc C., Zabouraa G., Fechnera S., and Fujimotoa T. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients. Eur J Cardiothorac Surg 22 (2002) 292-297
3. Alifano M., Boudaya M.S., Salvi M., Collet J.Y., Dinu C., Camilleri-Broët S., and Régnard J.F. Pneumonectomy after chemotherapy: morbidity, mortality, and long-term outcome. Ann Thorac Surg 85 (2008) 1866-1872
4. Fujita S., Katakami N., Takahashi Y., Hirokawa K., Ikeda A., Tabata C., Mio T., and Mishima M. Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer. Eur J Cardiothorac Surg 29 (2006) 896-901
5. Mansour Z., Kochetkova E.A., Ducrocq X., Vasilescu M.D., Maxant G., Buggenhout A., Wihlm J.M., and Massard G. Induction chemotherapy does not increase the operative risk of pneumonectomy!. Eur J Cardiothorac Surg 31 (2007) 181-185
6. Van Schil P., Van Meerbeeck J., Kramer G., Splinter T., Legrand C., Giaccone G., Manegold C., and van Zandwijk N. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Respir J 26 (2005) 192-197
7. Doddoli C., Barlesi F., Trousse D., Robitail S., Yena S., Astoul P., Giudicelli R., Fuentes P., and Thomas P. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 130 (2005) 416-425
8. Fowler W.C., Langer C.J., Curran Jr. W.J., and Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Annals Thorac Surg 55 (1993) 986-989
9. Gilligan D., Nicolson M., Smith I., Groen H., Dalesio O., Goldstraw P., Hatton M., Hopwood P., Manegold C., Schramel F., Smit H., van Meerbeeck J., Nankivell M., Parmar M., Pugh C., and Stephens R. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet 369 (2007) 1929-1937
10. Depierre A., Milleron B., Moro-Sibilot D., Chevret S., Quoix E., Lebeau B., Braun D., Breton J.L., Lemarie E., Gouva S., Paillot N., Brechot J.M., Janicot H., Lebas F.X., Terrioux P., Clavier J., Foucher P., Monchatre M., Coetmeur D., Level M.C., Leclerc P., Blanchon F., Rodier J.M., Thiberville L., Villeneuve A., Westeel V., and Chastang C. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
11. Nagai K., Tsuchiya R., Mori T., Tada H., Ichinose Y., Koike T., and Kato H. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). J Thorac Cardiovasc Surg 125 (2003) 254-260
12. Edelman M.J., Suntharalingam M., Burrows W., Kwong K.F., Mitra N., Gamliel Z., Riley M., Cooper L.B., Kennedy N.L., Buskirk S., Hausner P., Doyle L.A., and Krasna M.J. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer. Ann Thorac Surg 86 (2008) 903-910
13. Shaikh A.Y., Haraf D.J., Salama J.K., Salgia R., Hoffman P.C., Ferguson M.K., and Connell P.P. Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol 30 (2007) 258-263
14. Martin J., Ginsberg R.J., Abolhoda A., Bains M.S., Downey R.J., Korst R.J., Weigel T.L., Kris M.G., Venkatraman E.S., and Rusch V.W. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
15. Steger V., Walles T., Kosan B., Walker T., Kyriss T., Veit S., Dippon J., and Friedel G. Trimodal therapy for histologically proven N2/3 non small cell lung cancer: midterm results and indicators for survival. Ann Thorac Surg 87 (2009) 1676-1683
16. De Leyn P., Lardinois D., Van Schil P.E., Rami-Porta R., Passlick B., Zielinski M., Waller D.A., Lerut T., and Weder W. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32 (2007) 1-8
17. Liptay M.J., and Fry W.A. Complications from induction regimens for thoracic malignancies. Perioperative considerations. Chest Surg Clin North Am 9 (1999) 79-95
18. Walles T., Giere B., Hofmann M., Schanz J., Hofmann F., Mertsching H., and Macchiarini P. Experimental generation of a tissue-engineered functional and vascularized trachea. J Thorac Cardiovasc Surg 128 (2004) 900-906
19. Sacco O., Silvestri M., Sabatini F., Sale R., Defilippi A.C., and Rossi G.A. Epithelial cells and fibroblasts: structural repair and remodelling in the airways. Paediatr Respir Rev 5 Suppl. A (2004) S35-S40
20. Macchiarini P., Walles T., Biancosino C., and Mertsching H. First human transplantation of a bioengineered airway tissue. J Thorac Cardiovasc Surg 128 (2004) 638-641
21. Biancosino C., Zardo P., Walles T., Wildfang I., Macchiarini P., and Mertsching H. Generation of a bioartificial fibromuscular tissue with autoregenerative capacities for surgical reconstruction. Cytotherapy 8 (2006) 178-183
22. Walles T., Giere B., Macchiarini P., and Mertsching H. Expansion of chondrocytes in a three-dimensional matrix for tracheal tissue engineering. Ann Thorac Surg 78 (2004) 444-448
23. Bernard A., Deschamps C., Allen M.S., Miller D.L., Trastek V.F., Jenkins G.D., and Pairolero P.C. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg 121 (2001) 1076-1082
24. Deschamps C., Bernard A., Nichols F.C., Allen M.S., Miller D.L., Trastek V.F., Jenkins G.D., and Pairolero P.C. Empyema and bronchopleural fistula after pneumonectomy: factors affecting incidence. Ann Thorac Surg 72 (2001) 243-248